Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Laura R. Kauffman is active.

Publication


Featured researches published by Laura R. Kauffman.


Drug Metabolism and Disposition | 1999

Nonlinear Pharmacokinetics of Efavirenz (DMP-266), a Potent HIV-1 Reverse Transcriptase Inhibitor, in Rats and Monkeys

Suresh K. Balani; Laura R. Kauffman; Florencia A. deLuna; Jiunn H. Lin


Archive | 1991

Hydroxylated inhibitors of HIV reverse transcriptase.

Shieh-Shung Tom Chen; Annjia Hsu; George A. Doss; Mark E. Goldman; Suresh K. Balani; Anthony D. Theoharides; Jacob M. Hoffman; Steven M. Pitzenberger; Harri G. Ramjit; Laura R. Kauffman; Byron H. Arison; Walfred S. Saari; Clarence S. Rooney; John S. Wai


Drug Metabolism and Disposition | 1995

Species differences in the metabolism of a potent HIV-1 reverse transcriptase inhibitor L-738,372. In vivo and in vitro studies in rats, dogs, monkeys, and human.

Thomayant Prueksaritanont; Suresh K. Balani; L M Dwyer; Joan D. Ellis; Laura R. Kauffman; S L Varga; Steven M. Pitzenberger; Anthony D. Theoharides


Drug Metabolism and Disposition | 1992

Metabolism of a new HIV-1 reverse transcriptase inhibitor, 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one (L-696,229), in rat and liver slices

Suresh K. Balani; Steven M. Pitzenberger; Laura R. Kauffman; Byron H. Arison; Harri G. Ramjit; M E Goldman; J A O'Brien; J D King; J M Hoffman; C S Rooney


Drug Metabolism and Disposition | 1994

Metabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humans.

Suresh K. Balani; Laura R. Kauffman; Byron H. Arison; T V Olah; M E Goldman; S L Varga; J A O'Brien; Harri G. Ramjit; C S Rooney; J M Hoffman


Drug Metabolism and Disposition | 1993

Biotransformation of 5-chloro-3-phenylthioindole-2-carboxamide (L-734,005) in rhesus monkeys and rat liver microsomes to a potent HIV-1 reverse transcriptase inhibitor.

Suresh K. Balani; M E Goldman; Laura R. Kauffman; S L Varga; J A O'Brien; S J Smith; T V Olah; Harri G. Ramjit; T W Schorn; Steven M. Pitzenberger


Archive | 1993

Method of hydroxylating 3-[(4,7-dichlorobenzoxazol-2-yl)methyl]amino-5-ethyl-6-methyl-2-(1H)-pyridinone by incubation with liver slices

Suresh K. Balani; Anthony D. Theoharides; Laura R. Kauffman


Archive | 1992

Method of hydroxylating 3-[3-(5-ethyl-2-methoxy-6-methylpyridyl)methyl]amino-5-ethyl-6-methyl-2(1H)-pyridinone with liver slices

Suresh K. Balani; Laura R. Kauffman; Anthony D. Theoharides


Archive | 1991

Method of hydroxylating substituted 3-aminopyridinones using mammalian tissue

Suresh K. Balani; Byron H. Arison; Harri G. Ramjit; Anthony D. Theoharides; Laura R. Kauffman


Archive | 1991

Inhibiteurs hydroxylés de transcriptase inverse de HIV

Shieh-Shung Tom Chen; Annjia Hsu; George A. Doss; Mark E. Goldman; Suresh K. Balani; Anthony D. Theoharides; Jacob M. Hoffman; Steven M. Pitzenberger; Harri G. Ramjit; Laura R. Kauffman; Byron H. Arison; Walfred S. Saari; Clarence S. Rooney; John S. Wai

Collaboration


Dive into the Laura R. Kauffman's collaboration.

Top Co-Authors

Avatar

Anthony D. Theoharides

United States Military Academy

View shared research outputs
Top Co-Authors

Avatar

Steven M. Pitzenberger

United States Military Academy

View shared research outputs
Top Co-Authors

Avatar

John S. Wai

United States Military Academy

View shared research outputs
Researchain Logo
Decentralizing Knowledge